A narrative review of the challenges and countermeasures in hepatoblastoma management during COVID-19 epidemic.

ABSTRACT: An infectious disease named "coronavirus disease 2019" (COVID-19) currently has brought a threat to global health security and trends to be more and more severe in many countries. It also has introduced great challenges to the diagnosis and management of children with hepatoblastoma (HB). During the COVID-19 pandemic, pediatric surgeons should not only develop personalized treatment plans for HB therapy, but also emphasize the diagnosis, prevention, and treatment of this virus. Children with both HB and COVID-19 are recommended to undertake multidisciplinary assessment. Anti-SARS-CoV-2 therapy may be a preferred treatment for the infected without presenting a surgical emergency. However, emergent operation may be necessary for HB children with concurrent COVID-19 who developed a life-threa

SUBMITTER: Xu H 

PROVIDER: S-EPMC7804479 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature